ICID is featured in the latest edition of Insights by BIOTECanada. The article, written by ICID's CEO Heather Medwick and Medical Director Dr. Joel Kettner, explores ICID's role as a catalyst for Canadian and international collaborations resulting in innovative practices and products for public health. Read the excerpt below:
A Unique Business Emulsifier and Catalyst for the Bioeconomy
By Heather Medwick and Dr. Joel Kettner, International Centre for Infectious Diseases
The International Centre for Infectious Diseases (ICID) has established its niche as a business emulsifier and catalyst in the biotech/biomedical ecosystem. ICID’s founding in 2004 was inspired by a key insight: combating the global threat posed by infectious diseases requires a collaborative response that goes beyond traditional, siloed and disparate initiatives. It requires multi-sectoral, interdisciplinary and inter-professional engagement to harness the expertise of all the players involved in the complex world of medical biotechnology as it relates to research, policy and practice for prevention and treatment. ICID’s creators, including Dr. Frank Plummer of the Public Health Agency of Canada and Terry Duguid, ICID’s founding president and CEO, envisioned a not-for-profit, independent organization mandated to "work with government, universities and the private sector to bridge gaps that exist and coordinate the existing capabilities and strengths from across Canada’s infectious diseases sector."
READ MORE in Insights: Canada’s Voice for Biotechnology, 2015; Issue 2, pp. 18-23